Prof.Dr. ÖMER DİZDAR

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

The prognostic and predictive role of class III β-Tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma

Sahin T., IŞIK A., Guven D., Ceylan F., BABAOĞLU B., AKYOL A., et al.

Pancreatology , cilt.24, sa.2, ss.279-288, 2024 (SCI-Expanded)

Acute heart failure following pazopanib treatment: a literature review featuring two case reports

KERTMEN N., KAVGACI G., YILDIRIM H. Ç., DİZDAR Ö.

Anti-Cancer Drugs , cilt.35, sa.3, ss.302-304, 2024 (SCI-Expanded)

Sirolimus experience in adult patients with vascular malformations

AKYILDIZ A., Ismayilov R., GÜVEN D. C., YILDIRIM H. Ç., Tatar O. D., KUŞ F., et al.

Vascular , 2024 (SCI-Expanded)

Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.

Internal and Emergency Medicine , 2024 (SCI-Expanded)

Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy

Sahin T. K., ÖZBAY Y., ALTUNBULAK A. Y., ALTUNBULAK H. İ., ONUR M. R., Ceylan F., et al.

International Journal of Clinical Oncology , 2024 (SCI-Expanded)

A meta-analysis of the association between adjuvant chemoradiotherapy and disease-free survival in gastric cancer according to the histology

YILDIRIM H. Ç., GÜVEN D. C., AKYILDIZ A., YALÇIN Ş., DİZDAR Ö.

Irish Journal of Medical Science , cilt.192, sa.6, ss.2631-2634, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

AKYILDIZ A., GÜVEN D. C., Ozluk A. A., Ismayilov R., Mutlu E., Unal O. U., et al.

Medicine , cilt.102, sa.45, 2023 (SCI-Expanded)

A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer

YILDIRIM H. Ç., Ismayilov R., AKYILDIZ A., GÜVEN D. C., Abdurrahimli N., DİZDAR Ö., et al.

Anti-cancer drugs , cilt.34, sa.10, ss.1190-1192, 2023 (SCI-Expanded)

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia

AKTAŞ B. Y., ATA E. B., ÇEŞMECİ E., ÇAKIR İ. Y., Coşkunpınar M., TAHILLIOĞLU Y., et al.

Current Oncology , cilt.30, sa.11, ss.9689-9700, 2023 (SCI-Expanded)

Molecularly imprinted electrochemical sensor for the selective and sensitive determination of octreotide in cancer patient plasma sample

Ozkan E., Ozcelikay G., Gök Topak E. D., NEMUTLU E., ÖZKAN S. A., DİZDAR Ö., et al.

Talanta , cilt.263, 2023 (SCI-Expanded)

Advances in the Early Detection of Hepatobiliary Cancers

YILDIRIM H. Ç., KAVGACI G., Chalabiyev E., DİZDAR Ö.

Cancers , cilt.15, sa.15, 2023 (SCI-Expanded)

Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry

Duran E., Ozturk Z. O., BİLGİN E., BÜYÜKAŞIK Y., DİZDAR Ö., Yardimci G. K., et al.

Rheumatology and Therapy , cilt.10, sa.4, ss.969-981, 2023 (SCI-Expanded)

The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors

GÜVEN D. C., ÖZBEK D. A., ŞAHİN T. K., KAVGACI G., Aksun M. S., ERUL E., et al.

Anti-Cancer Drugs , cilt.34, sa.6, ss.783-790, 2023 (SCI-Expanded)

SMART syndrome: a case report

Bozkurt S., Toprak B., YILDIRIM H. Ç., PARLAK SAĞOL Ş., GÜVEN D. C., KERTMEN N., et al.

ACTA NEUROLOGICA BELGICA , cilt.123, sa.3, ss.1137-1140, 2023 (SCI-Expanded)

Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data

Sütcüoğlu O., Doğan A., Yilmaz F., Şahin A. B., ŞAHİN T. K., Esen S. A., et al.

Pancreas , cilt.52, sa.4, 2023 (SCI-Expanded)

Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer

Ceylan F., Guven D. C., Taban H., Aktepe O., ŞAHİN T. K., Kilickap S., et al.

Clinics and Research in Hepatology and Gastroenterology , cilt.47, sa.3, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy

GÜVEN D. C., Incesu F. G. G., YILDIRIM H. Ç., Erul E., Chalabiyev E., AKTAŞ B. Y., et al.

INTERNATIONAL JOURNAL OF CANCER , cilt.152, ss.679-685, 2023 (SCI-Expanded)

Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment

Guven D. C., YILDIRIM H. Ç., KUŞ F., Erul E., KERTMEN N., DİZDAR Ö., et al.

Expert Review of Anticancer Therapy , cilt.23, sa.10, ss.1049-1059, 2023 (SCI-Expanded)

Emerging treatment strategies in hepatobiliary cancer

GÜVEN D. C., YILDIRIM H. Ç., Chalabiyev E., KUŞ F., YILMAZ F., YAŞAR S., et al.

Expert Review of Anticancer Therapy , cilt.23, sa.3, ss.243-256, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards

GÜVEN D. C., EROĞLU İ., Ismayilov R., ULUSOYDAN E., AKTEPE O. H., TELLİ DİZMAN G., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.28, sa.8, ss.1807-1811, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Comparison of Clinical and Pathological Factors Affecting Early and Late Recurrences in Patients with Operable Breast Cancer

YEKEDÜZ E., DİZDAR Ö., KERTMEN N., AKSOY S.

JOURNAL OF CLINICAL MEDICINE , cilt.11, sa.9, 2022 (SCI-Expanded)

HER2-low breast cancer could be associated with an increased risk of brain metastasis

GÜVEN D. C., KAYA M. B., Fedai B., ÖZDEN M., YILDIRIM H. Ç., KÖSEMEHMETOĞLU K., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.27, sa.2, ss.332-339, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience

Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., TABAN H., et al.

FUTURE ONCOLOGY , cilt.18, ss.323-331, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better? Comment

Guven D. C., Taban H., Dizdar O.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.28, sa.1, ss.203-204, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study

GÜVEN D. C., YILDIRIM H. Ç., ERUL E., ŞAHİN T. K., ÇAKIR İ. Y., AKTEPE O. H., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.5, ss.1551-1558, 2022 (SCI-Expanded)

Correlation Between THSD7A Expression and Tumor Characteristics of Azoxymethane-Induced Colon Cancer Model in Rats

AKTEPE O. H., ŞAHİN T. K., GÜNER G., GÜVEN D. C., YETER H. H., KURTULAN O., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.32, sa.12, ss.1049-1056, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors

Guven D. C., Aktepe O. H., Aksun M. S., Sahin T. K., Kavgaci G., Ucgul E., et al.

ANNALS OF ONCOLOGY , cilt.32, 2021 (SCI-Expanded)

A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer

GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., AKTEPE O. H., DİZDAR Ö., YALÇIN Ş.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.168, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy

AKTEPE O. H., GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇELİKTEN B., Yeter H. H., et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.73, sa.10, ss.1957-1963, 2021 (SCI-Expanded)

Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality

GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇEŞMECİ E., Incesu F. G. G., TAHILLIOĞLU Y., et al.

BMJ SUPPORTIVE & PALLIATIVE CARE , 2021 (SCI-Expanded)

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy

GÜVEN D. C., AKSUN M. S., ŞAHİN T. K., AKTEPE O. H., YILDIRIM H. Ç., TABAN H., et al.

SUPPORTIVE CARE IN CANCER , cilt.29, sa.9, ss.5417-5423, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Lower prognostic nutritional index is associated with poorer survival in patients receiving immune-checkpoint inhibitors

GÜVEN D. C., AKTEPE O. H., TABAN H., AKTAŞ B. Y., GÜNER G., YILDIRIM H. H., et al.

BIOMARKERS IN MEDICINE , cilt.15, sa.13, ss.1123-1130, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Sarcopenia and anthracycline cardiotoxicity in patients with cancer

BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.

BMJ SUPPORTIVE & PALLIATIVE CARE , 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

PILE: a candidate prognostic score in cancer patients treated with immunotherapy

Guven D. C., Yildirim H. C., Bilgin E., Aktepe O. H., Taban H., Sahin T. K., et al.

CLINICAL & TRANSLATIONAL ONCOLOGY , cilt.23, sa.8, ss.1630-1636, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report

GÜVEN D. C., KILIÇKAP S., YILDIRIM H. Ç., Ceylan F., BAŞ O., DİZDAR Ö.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.5, ss.1281-1283, 2021 (SCI-Expanded)

THE INCIDENCE AND RISK FACTORS FOR ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A REAL-LIFE STUDY

GÜVEN D. C., ÖZBEK D. A., ŞAHİN T. K., AKSUN M. S., KAVGACI G., Cebrayilov C., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.36, 2021 (SCI-Expanded)

Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data

Ozdemir N., DİZDAR Ö., YAZICI O., AKSOY S., Dede D. S., Budakoglu B., et al.

INTERNATIONAL JOURNAL OF CANCER , cilt.148, sa.10, ss.2407-2415, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors

GÜVEN D. C., ŞAHİN T. K., AKSUN M. S., TABAN H., AKTEPE O. H., METİN AKSU N., et al.

SUPPORTIVE CARE IN CANCER , cilt.29, sa.4, ss.2029-2035, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Comments on "Survival impact of adjuvant chemotherapy in patients with stageIIAcolon cancer: Analysis of the National Cancer Database"

DİZDAR Ö.

INTERNATIONAL JOURNAL OF CANCER , cilt.148, sa.4, ss.1027, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

What to expect from NCCN BRCA testing criteria: A retrospective cohort analysis

Aktas B. Y., Degirmenciler R. F., Durmaz C. D., Taban H., Guven D. C., Guner G., et al.

ANNALS OF ONCOLOGY , cilt.32, 2021 (SCI-Expanded)

Prognostic and predictive value of tumor-infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer

Efil S. C., Guner G., Guven D. C., Celikten B., Celebiyev E., Taban H., et al.

ANNALS OF ONCOLOGY , cilt.32, 2021 (SCI-Expanded)

Cancer incidence in Behcet's disease

GÜVEN D. C., BÖLEK E. Ç., ALTINTOP S. E., ÇELİKTEN B., AKTAŞ B. Y., KİRAZ S., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , cilt.189, sa.4, ss.1209-1214, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives

C Guven D., ŞAHİN T. K., DİZDAR Ö., KILIÇKAP S.

BIOMARKERS IN MEDICINE , cilt.14, ss.1383-1392, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

All Positives May Not Be the Same in Pancreatic Cancer Lessons Learned From the Past

Ceylan F., GÜVEN D. C., ŞAHİN T. K., ÖZBEK D. A., DİZDAR Ö.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.43, sa.9, ss.676, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Cancer incidence in Behcet's Disease.

Guven D. C., Bolek E. C., Altintop S. E., Celikten B., Aktas B. Y., Kiraz S., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.38, sa.15, 2020 (SCI-Expanded)

Complete responses to two different anti-PD1 agents in a metastatic melanoma patient

KILIÇKAP S., GÜVEN D. C., AKTEPE O. H., AKTAŞ B. Y., DİZDAR Ö.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.2, ss.496-499, 2020 (SCI-Expanded)

The Effects of Different Treatment Modalities on the Disease Course and Survival in Patients with Hepatocellular Cancer

Lacin S., Karakas Y., DİZDAR Ö., KILIÇKAP S., Hassan M. M., Xiao L., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.30, sa.2, ss.94-102, 2020 (SCI-Expanded)

Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer

GÜVEN D. C., KILIÇKAP S., GÜNER G., TABAN H., DİZDAR Ö.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.1, ss.256-258, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Classifying sarcopenia: using median value or cut-off values?

BAŞ O., DİZDAR Ö.

BREAST CANCER RESEARCH AND TREATMENT , cilt.176, sa.2, ss.479, 2019 (SCI-Expanded)

Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy

AKTAŞ B. Y., Guner G., Guven D. C., Arslan C., DİZDAR Ö.

EXPERT REVIEW OF ANTICANCER THERAPY , cilt.19, sa.7, ss.589-601, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

Short-time use of crizotinib as neoadjuvant in ALK-positive non-small cell lung carcinoma can be a chance for resectability

KILIÇKAP S., Onder S., DİZDAR Ö., ERMAN M., ÜNER A.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.83, sa.6, ss.1195-1196, 2019 (SCI-Expanded)

Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia

BİLGİN E., DİZDAR Ö., Guven D. C., Ceylan S., AYBI Ö., FIRLATAN B., et al.

Rheumatology International , cilt.39, sa.6, ss.1045-1051, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients

Guven D. C., DİZDAR Ö., ALP A., AKDOĞAN KITTANA F. N., KARAKOÇ D., HAMALOĞLU E., et al.

BIOMARKERS IN MEDICINE , cilt.13, sa.9, ss.725-735, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

The frequency and predictors of persistent amenorrhea in premenopausal women with colorectal cancer who received adjuvant chemotherapy

ŞAHİN T., DİZDAR Ö., Ozdemir N., Zengin N., Ates O., Oksuzoglu B., et al.

ANTI-CANCER DRUGS , cilt.30, sa.3, ss.289-294, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

Evaluation of cancer risk in patients with periodontal diseases

Guven D. C., DİZDAR Ö., AKMAN A. C., Berker E., Yekeduz E., Ceylan F., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.3, ss.826-831, 2019 (SCI-Expanded)

Noninferiority for Short-HER or short-chemotherapy?

Aktas B. Y., Guven D. C., Dizdar O.

ANNALS OF ONCOLOGY , cilt.30, sa.1, ss.147, 2019 (SCI-Expanded)

Glucocorticoids in breast cancer treatment: real benefit or selection bias?

Guner G., DİZDAR Ö.

BREAST CANCER RESEARCH AND TREATMENT , cilt.172, sa.1, ss.243, 2018 (SCI-Expanded)

When side effect becomes the effect: Efficacy of capecitabine in refractory psoriasis

Karakas Y., Vural S., DIKER O., DİZDAR Ö.

DERMATOLOGIC THERAPY , cilt.31, sa.6, 2018 (SCI-Expanded)

EFFECTS OF CANCER TYPES ON LOCAL AND OUT-OF-CITY ADMISSIONS FOR MEDICAL CARE

HAYRAN K. M., Yuce D., Kilickap S., Dizdar O., Huseyin B., Erman M., et al.

VALUE IN HEALTH , cilt.21, 2018 (SCI-Expanded)

TRANSCULTURAL ADAPTATION OF EORTC-QLQ-CR29 SCALE INTO TURKISH, AND ASSESSMENT OF VALIDITY AND RELIABILITY IN TURKISH PATIENTS WITH COLORECTAL CANCER

HAYRAN K. M., Yuce D., Kilickap S., Huseyin B., Erman M., Dizdar O., et al.

VALUE IN HEALTH , cilt.21, 2018 (SCI-Expanded)

The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival

KARAKAS Y., DİZDAR Ö., AKSOY S., Hayran M., Altundag K.

CLINICAL BREAST CANCER , cilt.18, sa.4, ss.320-327, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

Familial Mediterranean fever: new insights into cancer immunoprevention? Comment on the article by Brenner et al

BİLGİN E., Erden A., DİZDAR Ö.

ARTHRITIS & RHEUMATOLOGY , cilt.70, sa.7, ss.1167, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey

ESİN E., YILDIZ F., Lacin S., KARAKAS Y., GÜLTEKİN M., DİZDAR Ö., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.4, ss.411-418, 2018 (SCI-Expanded)

Factors associated with quitting action following smoking cessation counseling.

Hayran K. M., Yuce D., Erman M., Dizdar O., Kilickap S., HUSEYIN B.

JOURNAL OF CLINICAL ONCOLOGY , cilt.36, sa.15, 2018 (SCI-Expanded)

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma

AKIN S., DİZDAR Ö., KARAKAS Y., Turker A., Kars A.

CURRENT PROBLEMS IN CANCER , cilt.42, sa.3, ss.344-349, 2018 (SCI-Expanded)

Fusobacterium and colorectal carcinogenesis

Guven D. C., DİZDAR Ö.

CARCINOGENESIS , cilt.39, sa.1, ss.84, 2018 (SCI-Expanded)

Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms

AKIN S., DİZDAR Ö., Hayran M.

ANNALS OF SURGICAL ONCOLOGY , cilt.24, 2017 (SCI-Expanded)

Tumor Sidedness and Prognosis in Colorectal Cancer: Is Microbiome the Missing Link?

KARAKAS Y., DİZDAR Ö.

JAMA ONCOLOGY , cilt.3, sa.7, ss.1000, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

Evaluation of complementary and alternative medicine trials registered in clinicaltrials.gov database

DİZDAR Ö., BİLGİN E., AKIN S., KILIÇKAP S., HAYRAN M.

JOURNAL OF BUON , cilt.22, sa.2, ss.530-534, 2017 (SCI-Expanded)

Increased cancer risk in patients with periodontitis

DİZDAR Ö., HAYRAN M., Guven D. C., YILMAZ T. B., TAHERI S., AKMAN A. C., et al.

CURRENT MEDICAL RESEARCH AND OPINION , cilt.33, sa.12, ss.2195-2200, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

Prognostic factors and treatment of patients with advanced synovial sarcoma: A single-center experience

Ates O., Aksoy S., Yeter H. H., Sunar V., Kertmen N., Dizdar O., et al.

INDIAN JOURNAL OF CANCER , cilt.54, sa.1, ss.321-325, 2017 (SCI-Expanded)

Vaccination perception and attitudes among patients with cancer receiving chemotherapy

AKIN Ş., DİZDAR Ö., Karakas Y., ÖZIŞIK L., Tanriover M. D., Kamisli S., et al.

ANNALS OF ONCOLOGY , cilt.27, 2016 (SCI-Expanded)

Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanes

Kucukoztas N., OĞUZ A., Rahatli S., Altundag O., Altundag K.

JOURNAL OF BUON , cilt.21, sa.5, ss.1076-1081, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

Interpretation of survival data: which graphical analysis is appropriate?

Dizdar O., AKIN S., HAYRAN M.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY , cilt.8, sa.4, ss.312, 2016 (SCI-Expanded)

Analysis of the Adjuvant Hormone Therapy Randomized Trial

Karakas Y., AKIN S., DİZDAR Ö., AKSOY S.

JOURNAL OF CLINICAL ONCOLOGY , cilt.34, sa.17, ss.2070-2071, 2016 (SCI-Expanded)

Cytoreductive Surgery for Intestinal Cancer Patients Metastatic to Ovaries Presenting as Primary Ovarian Cancer

Arik Z., Oz M., DİZDAR Ö., YILDIRIM M. E., OZGU E., TERZIOGLU S. G., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.2, ss.110-115, 2016 (SCI-Expanded)

Vaccination Attitudes Among Patients with Cancer Receiving Chemotherapy

AKIN S., DİZDAR Ö., ÖZIŞIK L., TANRIOVER M., KAMISLI S., ERMAN M., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.3, ss.167-172, 2016 (SCI-Expanded)

Advances in PARP inhibitors for the treatment of breast cancer

DİZDAR Ö., Arslan C., ALTUNDAG K.

EXPERT OPINION ON PHARMACOTHERAPY , cilt.16, sa.18, ss.2751-2758, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Is Dexamethasone a Better Partner for Abiraterone Than Prednisolone?

Dizdar O.

ONCOLOGIST , cilt.20, sa.5, 2015 (SCI-Expanded)

The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+breast cancer patients

BABACAN T., Balakan O., Kuzan T. Y., Sarici F., Koca E., KERTMEN N., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.50-56, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update

Arslan C., Dizdar O., ALTUNDAG K.

EXPERT OPINION ON PHARMACOTHERAPY , cilt.15, sa.12, ss.1643-1658, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Good Outcomes of Patients with Stage IB Endometrial Cancer with Surgery Alone

RAHATLI S., DİZDAR Ö., KÜÇÜKÖZTAŞ N., OĞUZ A., YALÇIN S., ÖZEN Ö., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.9, ss.3891-3893, 2014 (SCI-Expanded)

Tertiary Cancer Center Experience: Pregnancy-Associated Breast Cancer

Kuzas T. Y., Koca E., BABACAN T., Turkbeyler I. H., Sarici F., Altundag K.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.4, ss.284-285, 2014 (SCI-Expanded)

Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy

OZCAN M. F., Dizdar O., DINCER N., BALCI S., Guler G., GOK B., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , cilt.31, sa.8, ss.1709-1715, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Outcomes of locally advanced breast cancer patients with >= 10 positive axillary lymph nodes

KOCA E., KUZAN T. Y., Dizdar O., Babacan T., SAHIN I., ARARAT E., et al.

MEDICAL ONCOLOGY , cilt.30, sa.3, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Breast cancer in octogenarian women: clinical characteristics and outcome

Kuzan T. Y., Koca E., Dizdar O., Arslan C., Eren T., Yalcin S., et al.

JOURNAL OF BUON , cilt.18, sa.2, ss.328-334, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Association of breast cancer subtypes and body mass index

Petekkaya I., ŞAHİN U., Gezgen G., Solak M., YÜCE D., DİZDAR Ö., et al.

TUMORI J , cilt.99, sa.2, ss.129-133, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Safety of Tamoxifen During Pregnancy: 3 Case Reports and Review of the Literature

Koca E., Kuzan T. Y., BABACAN T., Turkbeyler I. H., Sarici F., Altundag K.

BREAST CARE , cilt.8, sa.6, ss.453-454, 2013 (SCI-Expanded)

Frequency of thyroid disease among breast cancer patients: a descriptive study of breast cancer patients

Vural O., Dizdar O., Petekkaya I., Alnak A., Babacan T., Altundag K.

JOURNAL OF BUON , cilt.18, sa.1, ss.294-295, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Impact of Treatment Strategies on Local Control and Survival in Uterine Carcinosarcomas in Turkey

Kucukoztas N., Dizdar O., Rahatli S., Dursun P., Yalcin S., Altundag O., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.5, ss.2959-2962, 2013 (SCI-Expanded)

Joint problems in breast cancer patients receiving adjuvant aromatase inhibitor

Kuria I. M., Petekkaya I., Hasanov E., Babacan T., Dizdar O., Altundag K.

JOURNAL OF BUON , cilt.17, sa.4, ss.798-799, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

Neuromyotonia forerunning the diagnosis of an eventual thymoma

Ozcakar L., Ozcan H. N., Dizdar O., Karaoglanoglu N., Tan E.

EUROPEAN JOURNAL OF NEUROLOGY , cilt.19, sa.9, 2012 (SCI-Expanded)

Frequency of HCV infection in renal cell carcinoma patients

Budakoglu B., Aksoy S., ARSLAN Ç., Uyeturk U., Babacan N. A., Ozcan M. F., et al.

MEDICAL ONCOLOGY , cilt.29, sa.3, ss.1892-1895, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

Phase II Study of Loading-Dose Ibandronate Treatment in Patients with Breast Cancer and Bone Metastases Suffering from Moderate to Severe Pain

Altundag K., DİZDAR Ö., ÖZSARAN Z., ÖZKÖK S., Saip P., Eralp Y., et al.

ONKOLOGIE , cilt.35, sa.5, ss.254-258, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

Breast cancer subtypes and outcomes of central nervous system metastases

Arslan U. Y., Oksuzoglu B., AKSOY S., Harputluoglu H., Turker I., Ozisik Y., et al.

BREAST , cilt.20, sa.6, ss.562-567, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer

BULUT N., AKSOY S., DİZDAR Ö., Dede D. S., Arslan C., DOĞAN E., et al.

MEDICAL ONCOLOGY , cilt.28, 2011 (SCI-Expanded)

Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response

ARSLAN Ç., AKSOY S., DİZDAR Ö., KURT M., Guler N., Ozisik Y., et al.

TUMORI , cilt.97, sa.6, ss.711-716, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Vitamin D intake may be effective in the management of triple-negative breast cancer

Harputluoglu H., Dizdar O., Karaahmet F., Altundag K.

JOURNAL OF BUON , cilt.16, sa.3, ss.569, 2011 (SCI-Expanded)

Pure mucinous carcinoma of the breast: a single center experience

Dogan E., Aksoy S., Dizdar O., Arslan C., Dede D. S., Ozisik Y., et al.

JOURNAL OF BUON , cilt.16, sa.3, ss.565-567, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Nilotinib is Effective in Imatinib and Sunitinib Resistant GIST: A Case Report

DİZDAR Ö., YALÇIN Ş.

HEPATO-GASTROENTEROLOGY , cilt.58, sa.107, ss.859-860, 2011 (SCI-Expanded)

Frequency of HCV infection in renal cell carcinoma patients

Budakoglu B., Aksoy S., Arslan C., Uyeturk U., Babacan N. A., Ozcan M. F., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.29, sa.15, 2011 (SCI-Expanded)

Clinicopathologic features of patients with breast cancer under teatment of bisphosphonate at the time of diagnosis: Retrospective analysis

Dede D. S., Arslan C., Aksoy S., Dizdar O., Dogan E., Alkan A., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.29, sa.15, 2011 (SCI-Expanded)

Percentage of family history of cancer in patients with breast cancer: Is it changing with ethnicity?

Dizdar O., Arslan C., Altundag K.

JOURNAL OF BUON , cilt.16, sa.2, ss.373, 2011 (SCI-Expanded)

Clinical and pathological characteristics of very young breast cancer patients (<= 25 years of age)

Ararat E., Sahin I., Arslan C., Aksoy S., Dizdar O., Ozisik Y., et al.

JOURNAL OF BUON , cilt.16, sa.2, ss.372, 2011 (SCI-Expanded)

Zoledronic acid and atrial fibrillation in cancer patients

ARSLAN Ç., AKSOY S., DİZDAR Ö., Dede D. S., HARPUTLUOĞLU H., ALTUNDAĞ M. K.

SUPPORTIVE CARE IN CANCER , cilt.19, sa.3, ss.425-430, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Ipsilateral Breast Cancer in a Patient with Poland's Syndrome

Yesilkaya Y., DİZDAR Ö., Altundag K.

AMERICAN SURGEON , cilt.77, sa.2, ss.234-235, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Malignancies after rituximab treatment: just coincidence or more?

Aksoy S., Arslan C., Harputluoglu H., Dizdar O., Altundag K.

JOURNAL OF BUON , cilt.16, sa.1, ss.112-115, 2011 (SCI-Expanded)

Blood ABO groups and risk of breast cancer

ŞENER DEDE D., AKSOY S., DİZDAR Ö., Cerci P., Gullu I., Ozisik Y., et al.

MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1433, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Other malignancies in patients with breast cancer: a single institute experience

Dogan E., AKSOY S., DİZDAR Ö., ŞENER DEDE D., ARSLAN Ç., Ozisik Y., et al.

MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1434-1435, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Two Important Determinants May Play a Role in the Success of the FinHer Trial

Isik M., DİZDAR Ö., Altundag K.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.20, 2010 (SCI-Expanded)

Renal safety and osteonecrosis of the jaw in cancer patients receiving intravenous bisphosphonates

AKSOY S., DİZDAR Ö., Altundag K.

MEDICAL ONCOLOGY , cilt.27, sa.2, ss.568, 2010 (SCI-Expanded)

Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.

Surmell Z. G., Aksoy S., Dizdar O., Dede D. S., Dogan E., Arslan C., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Systemic treatment in breast-cancer patients with brain metastasis

Arslan C., DİZDAR Ö., Altundag K.

EXPERT OPINION ON PHARMACOTHERAPY , cilt.11, sa.7, ss.1089-1100, 2010 (SCI-Expanded)

Phase II study of loading-dose ibandronate treatment in patients in breast cancer and bone metastases suffering from moderate to severe pain

Dizdar O., Altundag M. K., Ozkok S., Ozsaran Z., Saip P., Eralp Y., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2-positive breast cancer patients: Retrospective analysis.

Ozen M., Aksoy S., Dizdar O., Dede D. S., Dogan E., Arslan C., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?

Aksoy S., Arslan C., Kurt M., Dizdar O., Dede D. S., Dogan E., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded)

Skin metastasis of ovarian cancer: a rare entity

Arslan C., Dede D. S., Dizdar O., Altundag K.

JOURNAL OF BUON , cilt.15, sa.2, ss.398-399, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Clinical and pathological characteristics of breast cancer patients with history of tonsillectomy

Isik M., AKSOY S., Dede D. S., DİZDAR Ö., Kara A., Gullu I., et al.

BREAST , cilt.19, sa.2, ss.152, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Synchronous Ovarian Cancer in a Patient with Pleomorphic Lobular Breast Cancer: A Therapeutic Dilemma

Dizdar O., Arslan C., Altundag K.

CLINICAL ONCOLOGY , cilt.22, sa.2, ss.153-154, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Clinical and pathological characteristics of breast cancer patients with history of cesarean delivery

Kalan I., Turgut D., AKSOY S., ŞENER DEDE D., DİZDAR Ö., Ozisik Y., et al.

BREAST , cilt.19, sa.1, ss.67-68, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Estrogen receptor immunohistochemistry cutoff value: Standardization is needed

ARSLAN Ç., DİZDAR Ö., Altundag K.

HUMAN PATHOLOGY , cilt.41, sa.1, ss.150, 2010 (SCI-Expanded)

Sonographic and Electrodiagnostic Evaluations in Patients With Aromatase Inhibitor-Related Arthralgia

DİZDAR Ö., Oezcakar L., Malas F. U., HARPUTLUOĞLU H., Bulut N., Aksoy S., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.27, sa.30, ss.4955-4960, 2009 (SCI-Expanded)

Pharmacotherapy of triple-negative breast cancer

ARSLAN Ç., DİZDAR Ö., Altundag K.

EXPERT OPINION ON PHARMACOTHERAPY , cilt.10, sa.13, ss.2081-2093, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

Chemotherapy in Older Women with Breast Cancer

DİZDAR Ö., ŞENER DEDE D., Altundag K.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.361, sa.10, ss.1023, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

Reproductive and Hormonal Risk Factors for Postmenopausal Luminal, HER-2-overexpressing, and Triple-negative Breast Cancer

DİZDAR Ö., AKSOY S., Altundag K.

CANCER , cilt.115, sa.8, ss.1802, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

Pathological characteristics of very young (<= 30 years) breast cancer patients: a single-institution experience from Turkey

Aksoy S., Bulut N., Dizdar O., Tosur M., Meral A., Altundag K.

ANNALS OF ONCOLOGY , cilt.20, sa.4, ss.790, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

Emerging drugs in metastatic breast cancer

DİZDAR Ö., Altundag K.

EXPERT OPINION ON EMERGING DRUGS , cilt.14, sa.1, ss.85-98, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

Alterations of von Willebrand Factor and Ristocetin Cofactor Activity During Atrial Fibrillation

KALYONCU U., DİZDAR Ö., Duman A. E., KARADAĞ Ö., TUFAN A., Yucel O., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.15, sa.1, ss.103-108, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?

Dizdar O., Aksoy S., Altundag K.

ANNALS OF ONCOLOGY , cilt.20, sa.1, ss.189, 2009 (SCI-Expanded)

Prognostic factors in long-term breast cancer survivors with brain metastases

Harputluoglu H., Kara A., DİZDAR Ö., Surmeli Z. G., Altundag K.

BREAST CANCER RESEARCH AND TREATMENT , cilt.112, sa.1, ss.215, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Definition of postmenopausal status, age of the breast cancer patients and the outcome of aromatase inhibitors treatment

AKSOY S., DİZDAR Ö., Altundag K.

BREAST , cilt.17, sa.5, ss.433-435, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors

Harputluoglu H., DİZDAR Ö., Karaahmet F., Altundag K.

BREAST CANCER RESEARCH AND TREATMENT , cilt.110, sa.3, ss.541, 2008 (SCI-Expanded)

Weekly paclitaxel in the adjuvant treatment of breast cancer

AKSOY S., DİZDAR Ö., Altundag K.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.359, sa.3, ss.310, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

A case report: zoledronic acid-induced anterior uveitis

KILIÇKAP S., Ozdamar Y., ALTUNDAĞ M. K., DİZDAR Ö.

MEDICAL ONCOLOGY , cilt.25, sa.2, ss.238-240, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Vitamin D intake may be a predictor of response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer

DİZDAR Ö., Bulut N., Altundag K.

BREAST CANCER RESEARCH AND TREATMENT , cilt.109, sa.2, ss.403, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C

DİZDAR Ö., Tapan U., AKSOY S., Harputluoglu H., KILIÇKAP S., BARIŞTA İ.

EUROPEAN JOURNAL OF HAEMATOLOGY , cilt.80, sa.5, ss.381-385, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Aromatase inhibitor-associated arthralgia: Prevalence, clinical and serum parameters among Turkish postmenopausal breast cancer patients

Harputluoglu H., Dizdar O., Malas F. U., Ozcakar L., Bulut N., Ozisik Y., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.26, sa.15, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Clinicopathologic evaluation of non-Hodgkin lymphoma (NHL): A single centre experience

Kilickap S., Barista I., Turkmen E., Dizdar O., Aksoy S., Turker A., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.26, sa.15, 2008 (SCI-Expanded)

Characteristics of breast cancer patients with central nervous system metastases: A single-center experience

Harputluoglu H., DİZDAR Ö., AKSOY S., KILIÇKAP S., Dede D. S., Ozisik Y., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.100, sa.5, ss.521-526, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Prognostic impact of bone turnover markers in multiple myeloma

Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.26, sa.15, 2008 (SCI-Expanded)

Efficacy of chemotherapy for brain metastases from breast carcinoma: In regard to Le Scodan et al. (Int J Radia T Oncol Biol Phys 2007;69 : 839-845)

DİZDAR Ö., Tapan U., Altundag K.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.70, sa.5, ss.1615, 2008 (SCI-Expanded)

Prognostic factors in breast cancer patients with brain metastases

Harputluoglu H., DİZDAR Ö., Altundag K.

JOURNAL OF NEURO-ONCOLOGY , cilt.87, sa.2, ss.193, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Vitamin D supplementation and response to aromatase inhibitors in postmenopausal women with hormone-receptor positive breast cancer

DİZDAR Ö., Bulut N., Altundag K.

BREAST , cilt.17, sa.2, ss.120, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Erectile dysfunction in successfully treated lymphoma patients

AKSOY S., HARPUTLUOĞLU H., KILIÇKAP S., DİNÇER M., DİZDAR Ö., AKDOĞAN B., et al.

SUPPORTIVE CARE IN CANCER , cilt.16, sa.3, ss.291-297, 2008 (SCI-Expanded)

Familial chemosensitivity test: Can it be a predictive factor in the management of familial breast cancer?

DİZDAR Ö., Harputluoglu H., Altundag K.

BREAST , cilt.17, sa.1, ss.5, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines

DİZDAR Ö., ŞENER DEDE D., Bulut N., Altundag K.

BREAST CANCER RESEARCH AND TREATMENT , cilt.107, sa.2, ss.303, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer

Bulut N., Harputluoglu H., Dizdar O., Altundag K.

JOURNAL OF NEURO-ONCOLOGY , cilt.86, sa.2, ss.241, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

Potential targeted therapy options in the management of basal cell subtype of breast carcinoma

Harputluoglu H., DİZDAR Ö., Altundag K.

HUMAN PATHOLOGY , cilt.38, sa.12, ss.1869, 2007 (SCI-Expanded)

Efficacy of anastrozole on local recurrence in patients with favorable early breast cancer

DİZDAR Ö., Harputluoglu H., Altundag K.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.69, sa.5, ss.1651, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

Vitamin D intake and breast cancer risk in postmenopausal women

Dizdar O., Harputluoglu H., Altundag K.

ARCHIVES OF INTERNAL MEDICINE , cilt.167, sa.22, ss.2532, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

Bone mineral density in breast cancer patients with estrogen receptor-negative tumor

Dede D. S., Dizdar O., Harputluoglu H., Altundag K.

MATURITAS , cilt.58, sa.3, ss.324, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience

Aksoy S., Dizdar O., Harputluoglu H., Altundag K.

ANNALS OF ONCOLOGY , cilt.18, sa.11, ss.1904-1906, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

Rituximab-induced viral infections in lymphoma patients

Aksoy S., Harputluoglu H., Kilickap S., Dede D. S., Dizdar O., Altundag K., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.25, sa.18, 2007 (SCI-Expanded)

Predictive factors for metastasis in patients (pts) with gastric cancer

Kilickap S., Dizdar O., Harputluoglu H., Aksoy S., YALÇIN S. S.

JOURNAL OF CLINICAL ONCOLOGY , cilt.25, sa.18, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

Appropriate utilization of hospital beds in internal medicine: evaluation in a tertiary care hospital

Dizdar O., Karadag O., Kalyoncu U., Kurt M., ULGER Z., SARDAN Y. C., et al.

JOURNAL OF EVALUATION IN CLINICAL PRACTICE , cilt.13, sa.3, ss.408-411, 2007 (SCI-Expanded)

Research for bleeding tendency in patients presenting with significant epistaxis

Dizdar O., Onal I. K., Ozakin E., Karakilic E., Karadag O., Kalyoncu U., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.18, sa.1, ss.41-43, 2007 (SCI-Expanded)

Macrophage inflammatory protein-1 alpha: A link between innate immunity and familial mediterranean fever?

Dizdar O., Kalyoncu U., Karadag O., Akdogan A., Kiraz S., Ertenli I., et al.

CYTOKINE , cilt.37, sa.1, ss.92-95, 2007 (SCI-Expanded)

Rituximab-related viral infections in lymphoma patients

Aksoy S., Harputluoglu H., Kilickap S., Dede D. S., Dizdar O., Altundag K., et al.

LEUKEMIA & LYMPHOMA , cilt.48, sa.7, ss.1307-1312, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

Mucosa associated lymphoid tissue lymphoma of the sub mandibular gland presenting with relapse in the lacrimal gland

KURT M., Shorbagi A., ALTUNDAĞ M. K., AKYÖN YILMAZ Y., DİZDAR Ö., GÜLLÜ İ. H.

Leukemia , cilt.47, ss.1982-1984, 2006 (SCI-Expanded)

Coincidence of increased pulmonary artery pressure and patent septum foramen ovate in patients with solid tumors may have a propensity to develop central nervous system metastases

Harputluoglu H., Dizdar O., Altundag K.

MEDICAL HYPOTHESES , cilt.67, sa.4, ss.996, 2006 (SCI-Expanded)

Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma

Abali H., Eren O., Dizdar O., Karadag O., Erman M., Yilmaz A., et al.

LEUKEMIA & LYMPHOMA , cilt.46, sa.12, ss.1825-1828, 2005 (SCI-Expanded)

Seropositive arthritis in chronic lymphocytic leukemia: a remark on B cell-mediated autoimmunity

Onal I., Ozcakar L., Dizdar O., Buyukasik Y., Dundar S.

RHEUMATOLOGY INTERNATIONAL , cilt.25, sa.7, ss.569-570, 2005 (SCI-Expanded)

Orbital metastasis from adenocarcinoma of the colon

Dizdar O., Aksoy S., Kilickap S., Yalcin S.

SOUTHERN MEDICAL JOURNAL , cilt.98, sa.8, ss.846-847, 2005 (SCI-Expanded)

Group B streptococcal facet joint arthritis - Case report

Dizdar O., Alyamac E., Onal I., Uzun O.

SPINE , cilt.30, sa.14, 2005 (SCI-Expanded)

Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia

Dizdar O., Yurekli B., Purnak T., Aksu S., Haznedaroglu I.

ANNALS OF PHARMACOTHERAPY , cilt.38, ss.1319-1320, 2004 (SCI-Expanded)

Membranoproliferative glomerulonephritis associated with type 1 diabetes mellitus and Hashimoto's thyroiditis

Dizdar O., Kahraman S., Genctoy G., Ertoy D., Arici M., Altun B., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.19, sa.4, ss.988-989, 2004 (SCI-Expanded)

Obesity: an endocrine tumor?

Dizdar O., Alyamac E.

MEDICAL HYPOTHESES , cilt.63, sa.5, ss.790-792, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

Diğer Dergilerde Yayınlanan Makaleler

Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab

YILDIRIM H. Ç., KUŞ F., GÜVEN D. C., Karaca E., KAYGUSUZ Y., DİZDAR Ö., et al.

Journal of Immunotherapy and Precision Oncology , cilt.6, sa.4, ss.170-176, 2023 (Scopus)

Smoker Relatives of Inpatients: A Reasonable but Heterogeneous Target Population for Smoking Cessation Program

AKTAŞ B. Y., HÜSEYİN B., YÜCE D., DİZDAR Ö., ERMAN M., HAYRAN M., et al.

Archives of Basic and Clinical Research , cilt.5, sa.1, ss.178-184, 2023 (Hakemli Dergi)

Prognostic Value of Androgen Receptor Expression in Premenopausal Women with Estrogen Receptor-Positive Breast Cancer

YILDIRIM H. Ç., ÜNER M., Yildiran Özmen T., Chalabiyev E., GÜVEN D. C., KUŞ F., et al.

Journal of Oncological Science , cilt.9, sa.1, ss.33-37, 2023 (Scopus)

Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience

DEMİR M., Guven D., AKTAŞ B. Y., GÜNER G., AKTEPE O. H., TABAN H., et al.

SOUTH ASIAN JOURNAL OF CANCER , cilt.11, ss.287-292, 2022 (ESCI)

Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy

YILDIRIM H. Ç., GÜVEN D. C., AKTEPE O. H., TABAN H., YILMAZ F., YAŞAR S., et al.

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , cilt.6, sa.1, ss.59-63, 2022 (ESCI) Sürdürülebilir Kalkınma

Liquid biopsy: Novel perspectives on the importance and spectrum of PIK3CA, PTEN and RET mutations in solid tumors

Sahin I., Saat H., AKSOY S., DİZDAR Ö., Erdem H. B., Bahsi T.

MOLECULAR AND CLINICAL ONCOLOGY , cilt.16, sa.1, 2022 (ESCI)

Prognostic Factors Associated with Locally Advanced Gastric Cancer in Patients Treated with Adjuvant Chemotherapy

YILDIRIM H. Ç., Güven D. C., Chalabiyev E., Taban H., YILMAZ F., YAŞAR S., et al.

Journal of Oncological Science , cilt.8, sa.3, ss.143-147, 2022 (Scopus)

Turkish society of medical oncology covid-19 pandemic advisory board updated recommendations for medical oncologists: Included vaccination

Sümbül A. T., YALÇIN S. S., ÖZET A., ÜNAL S., DİZDAR Ö., AKBULUT H., et al.

Journal of Oncological Science , cilt.7, sa.1, ss.1-6, 2021 (Scopus)

Burnout syndrome during residency in internal medicine and pediatrics in a country without working time directive

YAZGAN AKSOY D., DURUSU TANRIÖVER M., ÜNAL S., DİZDAR Ö., KALYONCU U., KARAKAYA KARABULUT J., et al.

International Journal of Health Care Quality Assurance , 2014 (Scopus)

Multimodality Treatment in the Management of Anorectal Melanoma: A Case Report and Review of the Literature

Tapan U., DİZDAR Ö., Bulut N., ÇELİK İ.

EURASIAN JOURNAL OF MEDICINE , cilt.43, sa.3, ss.189-191, 2011 (ESCI)

Current and emerging treatment options in triple-negative breast cancer

DİZDAR Ö., Altundag K.

ONCOLOGY REVIEWS , cilt.4, sa.1, ss.5-13, 2010 (ESCI) Sürdürülebilir Kalkınma

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic

Guven D. C., Ceylan F., Cakir I. Y., Cesmeci E., Sayinalp B., Yesilyurt B., et al.

ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31

Changes in the outpatient and inpatient clinic admissions during COVID-19 pandemic: Anticipating and mitigating risks for cancer patients

Guven D. C., Aktas B. Y., Aksun M. S., Ucgul E., Sahin T. K., Yildirim H. C., et al.

ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31

Relationship between sarcopenia and anthracycline related cardiotoxicity in patients with cancer

Bas O., Erdemir A., Onur R., Guner G., Guven D. C., Aksu S., et al.

ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31

Daily chemotherapy and treatment unit in the COVID-19 era: Lessons of the first 60 days

Aktas B. Y., Guven D. C., Degirmenciler R. F., Taban H., Aktepe O. H., Kertmen N., et al.

ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31

Prognostic role of tumoral DNA damage repair protein expression in patients with resectable pancreatic cancer

Ceylan F., Guven D. C., Taban H., Aktepe O., Kilickap S., Turker A., et al.

ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31

outcomes of patients with resected pancreatic ductal adenocarcinoma

ceylan f., GÜVEN D. C., çakır y., Hamaloglu E., Karakoc D., TÜRKER F. A., et al.

9th international gastrointestinal cancer conference, 6 - 08 Aralık 2019

Clinicopathologic features of BRCA mutated breast cancer patients: Hacettepe experience

AKSOY S., DEĞİRMENCİLER R. F., AKTAŞ B. Y., Guven D. C., AKTEPE O. H., Guner G., et al.

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30 Sürdürülebilir Kalkınma

Embedded outpatient palliative care service within the oncology clinic: Preliminary experience in Hacettepe Oncology Hospital

Guven D. C., AKTEPE O. H., Berk Z., Guner G., Taban H., AKTAŞ B. Y., et al.

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30

MAY CANCER RISK BE DECREASED IN A LARGE COHORT OF CHILD AND ADULT FAMILIAL MEDITERRANEAN FEVER PATIENTS?

BİLGİN E., GÜVEN D. C., Ceylan S., AYBI ÖZDEMİR Ö., KARDAŞ R. C., FIRLATAN B., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.993

Effectiveness and safety of ferric carboxymaltose to treat iron deficiency anemia in cancer patients.

Aktas B. Y., Kayku V. E., Aslan A., Kertmen N., Dizdar Ö., Yalcin S., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37 Sürdürülebilir Kalkınma

Clinical features and prognosis of patients with liposarcoma: Single-center experience.

Demir M., Guven D. C., Aktas B. Y., Guner G., Aktepe O. H., Taban H., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37

TRANSCULTURAL ADAPTATION OF EORTC-QLQ-CR29 SCALE INTO TURKISH, AND ASSESSMENT OF VALIDITY ANDRELIABILITY IN TURKISH PATIENTS WITH COLORECTAL CANCER

HAYRAN K. M., YÜCE D., KILIÇKAP S., houssein b., ERMAN M., DİZDAR Ö., et al.

ISPOR Asia Pacific 2018, Tokyo, Japonya, 8 - 11 Kasım 2018, cilt.1, ss.11

EFFECTS OF CANCER TYPES ON LOCAL AND OUT-OF-CITY ADMISSIONS FOR MEDICAL CARE

HAYRAN K. M., YÜCE D., KILIÇKAP S., DİZDAR Ö., houssein b., ERMAN M., et al.

ISPOR Asia Pacific 2018, Tokyo, Japonya, 8 - 11 Kasım 2018 Sürdürülebilir Kalkınma

Kolorektal Kanserde 16S rDNA Sekanslama ile Oral Mikrobiyom Analizi

GÜVEN D. C., ERGÜNAY K., BRİNKMANN A., ALP A., AKDOĞAN KITTANA F. N., AKYÖN YILMAZ Y., et al.

2. Ulusal immünoterapi ve Onkoloji Kongresi, Antalya, Türkiye, 31 Ekim - 04 Kasım 2018 Sürdürülebilir Kalkınma

Compliance to the guideline of diagnostic tests in febrile neutropenic patients at a Turkish university hospital’

ZARAKOLU KÖŞKER I. P., AKOVA M., BÜYÜKAŞIK Y., DURUSU TANRIÖVER M., DİZDAR Ö., METAN G., et al.

20th Symposium on Infections in the immunocompromised host, Atina, Yunanistan, 17 - 19 Haziran 2018

Analysis of Fusobacterium nucleatum, Streptococcus gallolyticus and Porphyromonas gingivalis in saliva in colorektal patients and healty controls. Abst ID:”e15117”

GÜVEN D. C., DİZDAR Ö., ALP A., Akdoğan Kittana F. N., KARAKOÇ D., Hamaloğlu E., et al.

2018 ASCO, Chicago, Amerika Birleşik Devletleri, 1 - 05 Haziran 2018

Evaluation of cancer risk in patients with periodontal diseases.

GÜVEN D. C., DİZDAR Ö., AKMAN A. C., BERKER A. E., YEKEDÜZ E., CEYLAN F., et al.

2018 ASCO Annual Meeting, Chicago, Amerika Birleşik Devletleri, 1 - 05 Haziran 2018, cilt.36, ss.13571

Kolorektal Kanserli Hastalarda Ve Sağlıklı Kontrollerde Tükürükte Fusobacterium Nucleatum, Streptococcus Gallolyticus Ve Porphyromonas Gingivalis Analizi

GÜVEN D. C., DİZDAR Ö., ALP A., AKDOĞAN KITTANA F. N., KARAKOÇ D., HAMALOĞLU E., et al.

7. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018 Sürdürülebilir Kalkınma

Multimodality treatment in malignant peripheral nerve sheath tumors

KARAKAŞ Y., DİZDAR Ö., KÖSEMEHMETOĞLU K., GEDİKOĞLU M. G., SÖYLEMEZOĞLU A. F., BOZBULUT U. B., et al.

International Congress on oncological sciences, 28 Eylül - 01 Ekim 2017

Using Taylor Regression to Identify Points of Cahnge in Local Cancer Trends

HAYRAN K. M., YÜCE D., DİZDAR Ö.

GAP 2017 CONFERENCE, 9 - 11 Mayıs 2017 Sürdürülebilir Kalkınma

SEVERE PERIODONTITIS IS ASSOCIATED WITH INCREASED CANCER RISK

DİZDAR Ö., HAYRAN K. M., GÜVEN D. C., Yılmaz T. B., Taheri S., AKMAN A. C., et al.

GAP 2017 Conference, Texas, Amerika Birleşik Devletleri, 9 - 11 Mayıs 2017 Sürdürülebilir Kalkınma

Smoker relatives of inpatients: A reasonable but heterogeneous target population for smoking cessation program

AKTAŞ B. Y., HOUSSEİN b., YÜCE D., DİZDAR Ö., KILIÇKAP S., ERMAN M., et al.

7th ECTOH Conference on Tobacco or Health, Porto, Portekiz, 22 - 25 Mart 2017 Sürdürülebilir Kalkınma

Evaluating Admissions of Foreign Patients to a University Hospital in Turkey

HAYRAN K. M., YÜCE D., DENEK S., DİZDAR Ö.

International Forum for Quality Cancer Care, 27 - 29 Ekim 2016

Using geographical information systems to describe quality of life as a function of distance in cancer patients

HAYRAN K. M., ERMAN M., KILIÇKAP S., DİZDAR Ö., YÜCE D., HÜSEYİN B., et al.

ISPOR Asia Pacific Meeting 2016, 3 - 06 Eylül 2016, cilt.19, ss.892

The impact of the total size of lesions in multifocal multicentric breast cancer on survival

Karakaş Y., DİZDAR Ö., Akın S., ATEŞ Ö., ŞENDUR M. A. N., AKSOY S., et al.

2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016 Sürdürülebilir Kalkınma

Clinicopathologic characteristics of patients with recurrent or metastatic synovial sarcoma

ATEŞ Ö., AKSOY S., YETER H. H., Akın S., KERTMEN N., DİZDAR Ö., et al.

2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016

Intravenous ferric carboxymaltose treatment in cancer patients

ASLAN A., TAŞDEMİR V., KERTMEN N., DİZDAR Ö., AKSOY S.

2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016 Sürdürülebilir Kalkınma

Pleomorphic lobular carcinoma of the breast associated with impaired overall survival

Hacioglu M. B., Babacan T., Diker O., Akin S., Demir M., Dizdar O., et al.

European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51

Neuroendocrine breast cancer A single center experience

TAŞDEMİR V., Kertmen N., CENOLİ A., KESKİN Ö., KARAKAS Y., Diker Ö., et al.

2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015 Sürdürülebilir Kalkınma

Correlation of histopahologic response and prognostic markers with survival in locally advanced non-small cell lung cancer patients who have treated with neoadjuvant chemotherapy.

Kucukoztas N., Oguz A., Rahatli S., Dizdar O., Keskin G. S. Y., Ozyilkan O., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 Sürdürülebilir Kalkınma

Cytoreductive surgery for intestinal cancer patients metastatic to the adnexal presenting as primary ovarian cancer.

Arik Z., Dizdar O., Yildirim M. E., Ozgu E., Oz M., Terzioglu S. G., et al.

Signet ring cell carcinoma of breast: Single center experience.

AKIN S., DIKER O., KERTMEN N., ATEŞ Ö., DİZDAR Ö., YALÇIN Ş., et al.

Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes.

Oguz A., Babacan T., Dizdar O., Kucukoztas N., Rahatli S., Keskin G. S. Y., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32 Sürdürülebilir Kalkınma

Is there any correlation between molecular subtypes and blood groups in breast cancer?

Kucukoztas N., Oguz A., Babacan T., Dizdar O., Rahatli S., Sarici S. F., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32 Sürdürülebilir Kalkınma

Impact of treatment strategies on local control and survival in uterine carcinosarcomas.

Yalcin S., Dizdar O., Kucukoztas N., Rahatli S., Ozen O., Dursun P., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31

Impact of comorbidities on recurrence rates and survival in patients with endometrial cancer.

Kucukoztas N., Dizdar O., Rahatli S., Tarhan C., Haberal N., Dursun P., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31 Sürdürülebilir Kalkınma

Outcomes of patients with endometrial cancer and aggressive histology.

Rahatli S., Kucukoztas N., Dizdar O., Dursun P., Yalcin S., Haberal N., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31 Sürdürülebilir Kalkınma

Retrospective analysis of stage IIIc uterine carcinoma patients: A single center experience.

Yalcin S., Rahatli S., Kucukoztas N., Ozen O., Haberal N., Tarhan C., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30

Retrospective analysis of octagenarian breast cancer patients: Multicenter retrospective study.

Dizdar O., Arslan C., Eren T., Yalcin S., Kucukoztas N., Aksoy S., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 Sürdürülebilir Kalkınma

Retrospective analysis of stage IC uterine cancer patients: A single center experience.

Kucukoztas N., Yalcin S., Rahatli S., Ozen O., Haberal N., Tarhan C., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 Sürdürülebilir Kalkınma

Outcome of breast cancer patients with stage I diesease: A retrospective analysis

Ergun A., Kucukoztas N., Yalcin S., Rahatli S., Babacan T., Yagmurdur M. C., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 Sürdürülebilir Kalkınma

The Frequency and Determinants of Metabolic Syndrome in Patients with Operable Stage I-III Breast Cancer.

Aksoy S., Dizdar O., Dede D. S., Arslan C., Dogan E., Tapan U., et al.

32nd Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 9 - 13 Aralık 2009, cilt.69 Sürdürülebilir Kalkınma

Comparison of serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of metastases and serum levels at the time of first diagnosis

Dede D. S., Aksoy S., Bulut N., Dizdar O., Arik Z., Gullu I., et al.

45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2009, cilt.27 Sürdürülebilir Kalkınma

Zoledronic acid and atrial fibrillation in cancer patients with bone metastases

Aksoy S., Dizdar O., Turgut D., Dede D. S., Arslan C., Harputluoglu H., et al.

45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2009, cilt.27 Sürdürülebilir Kalkınma

Characteristics of breast cancer patients with central nervous system metastases and factors associated with survival after development of central nervous system metastasis

Harputluoglu H., Dizdar O., Aksoy S., Kilickap S., Dede D. S., Ozisik Y., et al.

30th Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 13 - 16 Aralık 2007, cilt.106 Sürdürülebilir Kalkınma

The correlations of plasma inflammatory markers and anti-nucleosome antibodies with SLEDAI

Kalyoncu U., Akdogan A., Calguneri M., Karadag O., Kisacik B., Apras S., et al.

Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237

Biochemical markers of bone turnover in the diagnosis of myeloma bone disease.

Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23

What does determine homocysteine levels in hemodialysis patients: Nutrition or inflammation?

Kahraman S., Genctoy G., Yilmaz R., Dizdar O., Arici M., Altun B., et al.

36th Annual Meeting of the American-Society-of-Nephrology, SAN DIEGO, CALIFORNIA, 12 - 17 Kasım 2003, cilt.14

Kitap & Kitap Bölümleri

Nutrition and Cachexia in Gastrointestinal Cancer Patients

HALİL M. G., Kuyumcu M. E., DİZDAR Ö., ÜLGER Z., YALÇIN Ş.

Textbook of Gastrointestinal Oncology, Yalçın Şuayib, Philip A. Philip, Editör, Springer, ss.379-394, 2019

esophaeal and gastroesophaeal junction tumors

YALÇIN Ş., DİZDAR Ö., KILIÇKAP S., cilbir e., philip p. a.

textbook of gastrointestinal oncology, Suayib Yalcin, Philip a. Philip, Editör, springer, ss.55-72, 2019

Metrikler

Yayın

229

Atıf (WoS)

841

H-İndeks (WoS)

Atıf (Scopus)

813

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler